Compared with postoperative stereotactic radiation therapy, an investigational intraoperative RT approach could significantly reduce local tumor recurrence and improve survival in patients with newly diagnosed operable brain metastases.
New findings could shift the standard approach to preventing brain metastases in SCLC, particularly as modern MRI allows clinicians to detect and treat brain disease earlier.
The imaging agent could potentially help doctors characterize a malignancy's aggression and identify lesions with a higher likelihood of invasion or metastasis.
A new review led by UCLA researchers examines the utility of commercially available AI tools for screening mammography and evidence surrounding their ability to detect interval cancers.
Armed with an advanced 7T MRI and one very committed graduate student, researchers are gaining new insight into how sleep patterns affect brain health.
University leaders, clinicians and industry partners recently gathered to celebrate the opening of the Imaging Research & Development Center on UC’s medical campus.
The REVEAL study has been assessing the sensitivity and specificity of iodine 124 evuzamitide (I 124 evuzamitide), a PET agent capable of visualizing signs of cardiac amyloidosis on imaging.
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](/sites/default/files/styles/240x220/public/2024-09/istock-1209664264.jpg.webp?itok=OEoT1RAi)